Mice were divided into 3 groups (n = 6mice/group): 4 million of untreated TC-1, 4 million of Cidofovir-pretreated TC-1 and 8 million of Cidofovir-pretreated TC-1.Toxicity of Cidofovir was assessed to make comparison between control and Cidofovir-treated cells possible.
An unpaired 2-tailed Student t test was used to make comparisons between control and diabetic groups.
In some studies, a posteriori tests performed by the authors such as the Bonferroni multiple comparison test [ 45, 71] or analysis of variance (ANOVA) were used to make comparisons between control and test groups or to determine whether obvious NMDR relationships exhibited a significant quadratic polynomial component [ 39, 40, 46].
CS improves scores on MMSE and ADAS-Cog in dementia, but benefits on the ADAS-Cog are generally not clinically significant and difficulties with blinding of patients and use of adequate placebo controls make comparison with the results of dementia drug treatments problematic.
This meta-analysis highlights important limitations in the literature such as difficulties with blinding of patients and use of adequate placebo controls, which make comparison with the results of dementia drug trials problematic.
Based on the results of this trial, sample sizes may be expanded to increase statistical power in order to make comparisons between the control and KAM-R group.
Conventional randomized phase II studies are intended to "select" a study treatment used for confirmatory studies from regimen candidates, whereas the phase 2.5 studies are carried out to "make comparisons" with a control group.
Phenotypic differences between parent offspring trios and non-trios have been reported for various psychiatric disorders, and it has been suggested that this may make comparisons of case-control and family-based results for gene-disease association studies inappropriate.
While our current study did not make comparisons to healthy controls, previous studies have found that median plasma or serum concentrations of IL-6, IL-1β, IL-1 receptor antagonist (IRAP) [ 16], neutrophil granule proteins, and CRP [ 17] were higher in CF patients versus healthy subjects.
If case control studies made comparison with >1 control group, the control group most representative of the healthy general population was used.
